Skandinaviska Enskilda Banken (SEB)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.1M | Sell |
56,000
-56,000
| -50% | -$26.9M | 1.06% | 19 |
|
|
2026
Q1 | $55.1M | Sell |
112,000
-137,600
| -55% | -$74.7M | 1.27% | 16 |
|
|
2025
Q4 | $145M | Sell |
249,600
-29,762
| -11% | -$16.8M | 0.58% | 30 |
|
|
2025
Q3 | $135M | Buy |
279,362
+63,248
| +29% | +$29.4M | 0.54% | 32 |
|
|
2025
Q2 | $87.6M | Sell |
216,114
-20,805
| -9% | -$8.7M | 0.38% | 51 |
|
|
2025
Q1 | $118M | Buy |
236,919
+62,312
| +36% | +$33.7M | 0.58% | 29 |
|
|
2024
Q4 | $90.6M | Sell |
174,607
-1,236
| -0.7% | -$680K | 0.41% | 40 |
|
|
2024
Q3 | $109M | Sell |
175,843
-816
| -0.5% | -$483K | 0.5% | 37 |
|
|
2024
Q2 | $97.7M | Sell |
176,659
-11,586
| -6% | -$6.64M | 0.47% | 38 |
|
|
2024
Q1 | $109M | Buy |
188,245
+57,149
| +44% | +$32.1M | 0.54% | 34 |
|
|
2023
Q4 | $69.6M | Sell |
131,096
-14,900
| -10% | -$7.21M | 0.4% | 41 |
|
|
2023
Q3 | $73.9M | Buy |
145,996
+9,133
| +7% | +$4.87M | 0.49% | 35 |
|
|
2023
Q2 | $71.4M | Sell |
136,863
-2,763
| -2% | -$1.49M | 0.47% | 40 |
|
|
2023
Q1 | $80.5M | Sell |
139,626
-3,089
| -2% | -$1.74M | 0.56% | 33 |
|
|
2022
Q4 | $78.6M | Sell |
142,715
-78,957
| -36% | -$41.8M | 0.59% | 32 |
|
|
2022
Q3 | $112M | Buy |
221,672
+64,905
| +41% | +$36.3M | 0.87% | 19 |
|
|
2022
Q2 | $85.2M | Sell |
156,767
-3,985
| -2% | -$2.19M | 0.63% | 33 |
|
|
2022
Q1 | $94.9M | Sell |
160,752
-15,136
| -9% | -$8.69M | 0.56% | 35 |
|
|
2021
Q4 | $117M | Sell |
175,888
-16,230
| -8% | -$10.1M | 0.6% | 31 |
|
|
2021
Q3 | $110M | Sell |
192,118
-5,418
| -3% | -$2.97M | 0.6% | 31 |
|
|
2021
Q2 | $99.7M | Sell |
197,536
-45,471
| -19% | -$21.5M | 0.61% | 29 |
|
|
2021
Q1 | $111M | Buy |
243,007
+70,556
| +41% | +$33.7M | 0.73% | 23 |
|
|
2020
Q4 | $80.3M | Buy |
172,451
+19,920
| +13% | +$9.34M | 0.55% | 33 |
|
|
2020
Q3 | $67.3M | Buy |
152,531
+6,820
| +5% | +$2.82M | 0.49% | 44 |
|
|
2020
Q2 | $52.8M | Buy |
145,711
+18,756
| +15% | +$6.29M | 0.43% | 53 |
|
|
2020
Q1 | $36M | Sell |
126,955
-8,984
| -7% | -$2.83M | 0.36% | 61 |
|
|
2019
Q4 | $44.2M | Buy |
135,939
+2,454
| +2% | +$744K | 0.35% | 66 |
|
|
2019
Q3 | $38.9M | Buy |
133,485
+51,340
| +62% | +$14.7M | 0.33% | 72 |
|
|
2019
Q2 | $24.1M | Buy |
82,145
+6,060
| +8% | +$1.67M | 0.21% | 101 |
|
|
2019
Q1 | $20.8M | Buy |
76,085
+1,285
| +2% | +$320K | 0.19% | 114 |
|
|
2018
Q4 | $16.7M | Buy |
74,800
+7,404
| +11% | +$1.74M | 0.15% | 126 |
|
|
2018
Q3 | $16.4M | Sell |
67,396
-3,010
| -4% | -$692K | 0.13% | 141 |
|
|
2018
Q2 | $14.6M | Buy |
70,406
+21,950
| +45% | +$4.66M | 0.12% | 134 |
|
|
2018
Q1 | $10M | Sell |
48,456
-23,114
| -32% | -$4.85M | 0.1% | 146 |
|
|
2017
Q4 | $13.6M | Buy |
71,570
+3,380
| +5% | +$648K | 0.12% | 148 |
|
|
2017
Q3 | $12.9M | Buy |
68,190
+3,100
| +5% | +$561K | 0.12% | 161 |
|
|
2017
Q2 | $11.4M | Buy |
65,090
+1,775
| +3% | +$298K | 0.11% | 178 |
|
|
2017
Q1 | $9.72M | Buy |
63,315
+930
| +1% | +$142K | 0.1% | 188 |
|
|
2016
Q4 | $8.8M | Sell |
62,385
-4,748
| -7% | -$700K | 0.11% | 159 |
|
|
2016
Q3 | $10.7M | Buy |
67,133
+2,900
| +5% | +$447K | 0.12% | 143 |
|
|
2016
Q2 | $9.49M | Sell |
64,233
-12,000
| -16% | -$1.77M | 0.11% | 147 |
|
|
2016
Q1 | $10.8M | Buy |
76,233
+9,675
| +15% | +$1.3M | 0.12% | 129 |
|
|
2015
Q4 | $9.44M | Buy |
+66,558
| New | +$8.88M | 0.12% | 127 |
|
Other funds holding TMO
Skandinaviska Enskilda Banken (SEB)'s TMO Position: Q2 2026 in Review
Skandinaviska Enskilda Banken (SEB) reduced its Thermo Fisher Scientific (TMO) stake by 50% in Q2 2026, selling an estimated $26.9M and leaving 56,000 shares worth $28.1M. The position accounts for 1.06% of the portfolio, ranked #19.
Skandinaviska Enskilda Banken (SEB) first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. The position peaked at $145M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Skandinaviska Enskilda Banken (SEB) held 56,000 shares of Thermo Fisher Scientific worth $28.1M as of Q2 2026.
- Skandinaviska Enskilda Banken (SEB) sold 56,000 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.9M.
- Thermo Fisher Scientific made up 1.06% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q2 2026, its #19 holding.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
- Skandinaviska Enskilda Banken (SEB)'s Thermo Fisher Scientific position peaked at $145M in Q4 2025.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2026, filed 10 Aug 2026.